We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Carclo Plc | LSE:CAR | London | Ordinary Share | GB0001751915 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.65 | 18.50 | 18.90 | - | 0.00 | 08:00:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 143.45M | -3.96M | -0.0539 | -3.46 | 13.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/11/2020 10:46 | It becomes nonsense to you if you don't like hearing other views...the contract has to be full filled first...there could well be clauses on cancellation etc etc under the circumstances...unde | diku | |
27/11/2020 10:34 | Nonsense, the whole idea of public statements is to let shareholders and stakeholders know how the company is performing when there is a material change (good or bad) to the company's finances! How else are the stakeholders going to find out? They had a legal duty to announce the new deals when they were signed and they failed to do so! | topnotch | |
27/11/2020 10:31 | That happens in comedy only...revealing the figures would be like bragging...Trump is good at it like Dow 30k 30k 30k...special news conference just for that... | diku | |
27/11/2020 10:13 | That makes no sense whatsoever - you want to crush your enemies (as Borat would say) | topnotch | |
27/11/2020 10:11 | Generally best not to reveal the size of the deal...it spooks competition... | diku | |
27/11/2020 10:07 | Any ideas or estimates on the size of the Avacta deal? | topnotch | |
27/11/2020 09:54 | Carclo will be far more positive about prospects if they have to defend a takeover, which I think is possible given the restructure and the capacity shortage across the industry. I hope that the CV19 test is Avacta’s – the timing fits. If so, they will be under an NDA. | vsb234 | |
27/11/2020 09:47 | Results show the massive sensitivity to AA corporate bond yields. The 80bp reduction to 1.5% between end March and end September resulted in a £20m increase in the pension deficit. That's not pleasant! But this is very cheap exposure to that yield volatility. If yields continue to fall, life gets a bit harder here. But if they start to rise back up again, that value is quickly moved from pension hands into shareholder hands. Agree additionally with binliners points - the exceptional costs will start to fall out. Note the £1m+ cost taken in the half relating to the trustee agreement that will not be repeated going forward. It's a slow burner but I continue to think the risk/reward on a 1-3 year view looks attractive. | wigwammer | |
27/11/2020 09:26 | The PR department needs replacing | topnotch | |
27/11/2020 09:10 | On exceptional costs from the Wipac exit.. Total exceptional costs were GBP -11.7M Exceptional costs accounted for FY2019 were -4.7M Exceptional costs accounted for FY2020 were -5.47M Exceptional costs accounted for H1-2021 were -1.3M Exceptional costs now accounted for 11.47M H1-2020 Cash credit of +0.5M So we should have cleared the decks now, and all the associated costs from the Wipac exit are worked through...? giving us much more headroom for H2/FY and forward profitability..? Does anyone agree or disagree....? and why..? | laurence llewelyn binliner | |
27/11/2020 08:34 | "Two significant tooling agreements were secured with a new medical customer for COVID-19 test components with supply of manufactured product due to commence in 2021" They could have at least mentioned what the financial impact of this 'significant agreement' would be to the bottom line 1. When were these orders secured 2. How much are the orders worth over lifetime 3. Were any upfront payments made Why wasn't an RNS released when these orders were signed - like EVERY other company would have done? | topnotch | |
27/11/2020 08:29 | slightly underwhelming presentation - imv could have been a bit more upbeat | 9degrees | |
27/11/2020 08:19 | The CFO of Capita left 2 weeks ago when the price was 37p and the price went up to 50p | topnotch | |
27/11/2020 08:18 | Market never likes it when the finance man decides to leave. | meijiman | |
27/11/2020 08:11 | Well, we are still in business and picking up some new plastics orders, group net debt is reduced, and the exceptional costs from the Wipac sale are worked through.. Some small progress, with H2 recovery outlook stronger, harshly marked down but the company is only just starting its route back to financial health.. | laurence llewelyn binliner | |
27/11/2020 08:10 | Market doesn't like the results | topnotch | |
27/11/2020 07:48 | 2021 financial year is from March 2020 to March 2021 explained in the RNS text. | mikec365 | |
27/11/2020 07:09 | They can't even get the year right!!-- H1 2021 saw resilient performances from the two continuing businesses (Aerospace and Technical Plastics) in the context of COVID-19. | cl0ckw0rk0range | |
26/11/2020 20:56 | Seems to be some buys today, share price might be being manipulated UC trade looks suspicious plus I added today on the odd chance outlook would be more favourable. My trade does not show up today, I know the amount... | beeezzz | |
26/11/2020 16:14 | All aboard.. :o) hold onto your hats, it might get bumpy tomorrow morning .. My hopes are this is the start or 1st glimpse of the long road to recovery, we are in a mainly pandemic driven recovery stock by product design, an event triggered outside of our control but to our advantage, good luck to all holders.. | laurence llewelyn binliner | |
26/11/2020 15:56 | There wasn't an imminent event at that point so I was happy to let it run. | 1gw | |
26/11/2020 15:17 | I have high hopes that technical plastics will ride to the rescue | robow | |
26/11/2020 14:34 | I've taken some off the table there. Too many disappointments in the past with this share to let it all ride into tomorrow's results. | 1gw | |
26/11/2020 14:10 | Nearly there, and results in the morning, best to manage our expectations, BUT, there will be no more drain on resources from Wipac outside of the exceptional costs being worked through in 2020, underlying profits from the medical plastics plants will have improved in Q2, but by how much..?, Aerospace we know will be weaker but this is a smaller part of the groups activities.., Q3/Q4 will be stronger still and yet to be reported, but some post period notes will be enlightening.. :o) | laurence llewelyn binliner |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions